| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8237807 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 8 Pages |
Abstract
Capecitabine with MMC and RT in with patients anal carcinoma is well tolerated, with minimal toxicity and acceptable compliance. We recommend testing this schedule in future national Phase III studies in anal cancer.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Rob M.D., Helen M.Sc., Susan B.Sc., Simon M.D., Martin M.D., Ed M.D., Alec C. M.D., Sun M.D., Les M.D., David M.D.,